Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The impact of pre-analytical processing on staining quality for H&E, dual hapten, dual color in situ hybridization and fluorescent in situ hybridization assays.
Babic A, Loftin IR, Stanislaw S, Wang M, Miller R, Warren SM, Zhang W, Lau A, Miller M, Wu P, Padilla M, Grogan TM, Pestic-Dragovich L, McElhinny AS. Babic A, et al. Among authors: grogan tm. Methods. 2010 Dec;52(4):287-300. doi: 10.1016/j.ymeth.2010.08.012. Epub 2010 Aug 31. Methods. 2010. PMID: 20807574
A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections.
Nitta H, Kelly BD, Padilla M, Wick N, Brunhoeber P, Bai I, Singh S, Ranger-Moore J, Bieniarz C, Tsuda H, Grogan TM. Nitta H, et al. Among authors: grogan tm. Diagn Pathol. 2012 May 30;7:60. doi: 10.1186/1746-1596-7-60. Diagn Pathol. 2012. PMID: 22647525 Free PMC article.
New methods for ALK status diagnosis in non-small-cell lung cancer: an improved ALK immunohistochemical assay and a new, Brightfield, dual ALK IHC-in situ hybridization assay.
Nitta H, Tsuta K, Yoshida A, Ho SN, Kelly BD, Murata LB, Kosmeder J, White K, Ehser S, Towne P, Schemp C, McElhinny A, Ranger-Moore J, Bieniarz C, Singh S, Tsuda H, Grogan TM. Nitta H, et al. Among authors: grogan tm. J Thorac Oncol. 2013 Aug;8(8):1019-31. doi: 10.1097/JTO.0b013e31829ebb4d. J Thorac Oncol. 2013. PMID: 23817194 Free article.
BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma.
Kendrick SL, Redd L, Muranyi A, Henricksen LA, Stanislaw S, Smith LM, Perry AM, Fu K, Weisenburger DD, Rosenwald A, Ott G, Gascoyne RD, Jaffe ES, Campo E, Delabie J, Braziel RM, Cook JR, Tubbs RR, Staudt LM, Chan WC, Steidl C, Grogan TM, Rimsza LM. Kendrick SL, et al. Among authors: grogan tm. Hum Pathol. 2014 Oct;45(10):2144-53. doi: 10.1016/j.humpath.2014.06.005. Epub 2014 Jun 26. Hum Pathol. 2014. PMID: 25090918 Free PMC article.
Silver in situ hybridization (SISH) for determination of HER2 gene status in breast carcinoma: comparison with FISH and assessment of interobserver reproducibility.
Papouchado BG, Myles J, Lloyd RV, Stoler M, Oliveira AM, Downs-Kelly E, Morey A, Bilous M, Nagle R, Prescott N, Wang L, Dragovich L, McElhinny A, Garcia CF, Ranger-Moore J, Free H, Powell W, Loftus M, Pettay J, Gaire F, Roberts C, Dietel M, Roche P, Grogan T, Tubbs R. Papouchado BG, et al. Am J Surg Pathol. 2010 Jun;34(6):767-76. doi: 10.1097/PAS.0b013e3181d96231. Am J Surg Pathol. 2010. PMID: 20421783
A new rabbit monoclonal antibody (4B5) for the immunohistochemical (IHC) determination of the HER2 status in breast cancer: comparison with CB11, fluorescence in situ hybridization (FISH), and interlaboratory reproducibility.
Powell WC, Hicks DG, Prescott N, Tarr SM, Laniauskas S, Williams T, Short S, Pettay J, Nagle RB, Dabbs DJ, Scott KM, Brown RW, Grogan T, Roche PC, Tubbs RR. Powell WC, et al. Appl Immunohistochem Mol Morphol. 2007 Mar;15(1):94-102. doi: 10.1097/pai.0b013e31802ced25. Appl Immunohistochem Mol Morphol. 2007. PMID: 17536315
233 results